BDNF and myeloid sarcoma: Further studies can consider using anti-miR-191 therapy in order to upregulate the BDNF levels since BDNF promotes neuronal growth and survival and has been demonstrated to be a potential therapy for decreasing neurodegeneration in MS [91].